Seer maintains 2026 revenue guidance of $16 mln to $18 mln
Overview
U.S. proteomics technology provider's Q2 revenue fell 23% yr/yr due to macroeconomic headwinds
Net loss for Q2 narrowed as operating expenses declined 19% yr/yr
Company repurchased about 200,000 shares under its share repurchase program
Analyst coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the office equipment peer group is "buy"
Wall Street's median 12-month price target for Seer, Inc. is $4.00, about 85.2% above its August 10 closing price of $2.16
Result drivers and key details
MACROECONOMIC HEADWINDS - Co said lower product and service revenue was primarily due to continued macroeconomic headwinds in academic and government funding
LONGER SALES CYCLES - Co cited continued elongation of sales cycles in some commercial accounts related to extended customer evaluations
SEER•
